JaneLGilmoreMD

PubMed

• Volumetric evaluation of an alternative bladder point in brachytherapy for locally advanced cervical cancer.
  Mazeron R, Gilmore J, Champoudry J, Dumas I, Helou J, Maroun P, Martinetti F, Gerbaulet A, Haie-Meder C> ;Strahlenther Onkol. 2014-01-01
• [Locally advanced cervical cancer: Should intensity-modulated radiotherapy replace brachytherapy?].
  Mazeron R, Gilmore J, Khodari W, Dumas I, Haie-Méder C> ;Cancer Radiother. 2011-10-01
• Review: imaging of groin pain in the athlete.
  Davies AG, Clarke AW, Gilmore J, Wotherspoon M, Connell DA> ;Skeletal Radiol.. 2010-07-01
• 37 citations
  Conivaptan for hyponatremia in the neurocritical care unit.
  Wendy L. Wright, William Asbury, Jane L. Gilmore, Owen Samuels> ;Neurocritical Care. 2009 Jan 1
• Hematologic and transfusion outcomes following implementation of the erythropoiesis-stimulating agent (ESA) National Coverage Determination (NCD) in Medicare cancer pa...
  Gilmore J, Feinberg BA, Gondesen T, Jackson J, Bookhart BK, McKenzie RS> ;J. Clin. Oncol.. 2008-05-20
• 160 citations
  Peripheral neuropathy associated with prolonged use of linezolid.
  Adam M. Bressler, Shanta M. Zimmer, Jane L Gilmore, Jyoti Somani> ;The Lancet. Infectious Diseases. 2004 Aug 1
• Lack of association between an interleukin 1 beta (IL-1beta) gene variation and refractory temporal lobe epilepsy.
  Buono RJ, Ferraro TN, O'Connor MJ, Sperling MR, Ryan SG, Scattergood T, Mulholland N, Gilmore J, Lohoff FW, Berrettini WH> ;Epilepsia. 2001-06-01
• An evaluation of hospital cleaning regimes and standards.
  Griffith CJ, Cooper RA, Gilmore J, Davies C, Lewis M> ;J. Hosp. Infect.. 2000-05-01
• Benzenesulfonamide derivatives of 2-substituted 4H-3,1-benzoxazin-4-ones and benzthiazin-4-ones as inhibitors of complement C1r protease.
  Plummer JS, Cai C, Hays SJ, Gilmore JL, Emmerling MR, Michael W, Narasimhan LS, Watson MD, Wang K, Nath R, Evans LM, Jaen JC> ;Bioorg. Med. Chem. Lett.. 1999-03-22
• Body mass index and health.
  Gilmore J> ;Health Rep. 1999-01-01
• Groin pain in the soccer athlete: fact, fiction, and treatment.
  Gilmore J> ;Clin Sports Med. 1998-10-01
• Stroke: therapeutic approaches.
  Gilmore J, Horton R> ;Drug News Perspect.. 1998-09-01
• 5 citations
  MEDICATION USE DURING PREGNANCY FOR NEUROLOGIC CONDITIONS
  Jane L Gilmore, Page B. Pennell, Barney J. Stern> ;Neurologic Clinics. 1998 Feb 1
• Reduction of interferon-gamma as a critical mechanism by which ultraviolet radiation prevents tumor rejection.
  Gensler HL, Simpson J, Gerrish K, Gilmore J> ;Photochem. Photobiol.. 1995-11-01
• The pharmacology of LY290324 in the guinea-pig: an orally active, potent and selective cysteinyl leukotriene receptor antagonist.
  Boot JR, Bond A, Thomas KH, O'Brien A, Gilmore J, Todd A> ;Eur. J. Pharmacol.. 1993-01-26
• Endogenously formed leukotriene C4 activates LTC4 receptors in guinea pig tracheal strips.
  Snyder DW, Cho HL, Gilmore J> ;Eur. J. Pharmacol.. 1991-03-26
• The rare presentation to the cosmetic and plastic surgeon of a patient with myxedema.
  Gilmore J, Mellon D> ;Ann Plast Surg. 1990-12-01
• PICO: 1987 in review.
  Gilmore J> ;Ohio Med. 1988-03-01
• Clinical photography utilizing office staff: methods to achieve consistency and reproducibility.
  Gilmore J, Miller W> ;J Dermatol Surg Oncol. 1988-03-01
• Uptake and degradation of lipoproteins by human trophoblastic cells in primary culture.
  Winkel CA, Gilmore J, MacDonald PC, Simpson ER> ;Endocrinology. 1980-12-01
• Join now to see all